Immunoglobulin heavy variable 1-2 (IGHV1-2)

Immunoglobulin heavy variable 1-2 (IGHV1-2) encodes a variable region gene segment used in assembling the variable domain of the heavy chain of immunoglobulins (antibodies)[1]. This gene segment participates in V-(D)-J rearrangement in developing B lymphocytes, allowing for the creation of a vast repertoire of antigen-binding sites essential for adaptive immunity[2]. The resulting variable region, when paired with a light chain, forms the antigen-binding site of the antibody[4][5]. Variability arises both from genetic recombination and somatic hypermutation after antigen exposure, contributing to high affinity and specificity of the immune response[1][2][5]. IGHV1-2 is one of many variable region genes and shows polymorphic allelic diversity in humans[3]. While not itself a therapeutic target, it is of interest in immune repertoire analysis and certain research or diagnostic applications, especially in the context of B cell neoplasms where clonal usage of IGHV genes (including IGHV1-2) may be detected[6]. IGHV1-2 does not function as a receptor, enzyme, or channel and is not a direct target of any therapeutics; rather, it contributes to the generation of antibodies, which themselves may be therapeutic or disease relevant[1][4][5].

Other names

IGHV1-2V35Ig heavy chain V-I region NDIg heavy chain V-I region V35IGHV12

Not applicable. No approved drugs act by targeting IGHV1-2.